<DOC>
	<DOCNO>NCT03019289</DOCNO>
	<brief_summary>The purpose study demonstrate engagement pridopidine S1R D2R ( optional ) live human brain . No formal statistical analysis conduct</brief_summary>
	<brief_title>A Study Evaluate Sigma-1 Dopamine-2 Receptor Occupancy Pridopidine Human Brain Healthy Volunteers Patients With Huntington 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>In general , good physical health determine medical history psychiatric history , suicidality assessment &amp; physical examination Men potentially fertile ( surgically [ eg , vasectomy ] congenitally sterile Patients Huntington 's disease ( HD ) : diagnosis HD onset HD 18 year age Additional criterion apply , please contact investigator information The subject previously expose ionize radiation radioactive substance result clinical research medical treatment past 10 year . The subject counterindication MRI History alcohol , narcotic , substance dependence past 2 year Additional Exclusion criterion patient Huntington 's disease : The patient severe motor impairment might cause artifact . Patients known history Long QT Syndrome first degree relative condition . Treatment investigational product within 6 week screen patient plan participate another clinical study assess investigational product study . Additional criterion apply , please contact investigator information</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>